Cardinal Health’s sell-off on earnings was an overreaction. We’d be buyers
We’ve taken a closer look at Cardinal Health’s quarterly results and conference call following Thursday’s sell-off. Our conclusion: The 4.9% decline was an overreaction, and we would be buyers on Friday morning if not restricted. Note: We’re prevented from trading stocks that Jim Cramer mentions […]
Health
